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Abstract 
 Methodological differences between studies of cross-cultural menopausal symptoms limit 
attempts at comparison or systematic review. The purpose of this paper is to provide an overview 
of methods used in cross-cultural studies of menopausal symptoms and to make general 
recommendations for increasing methodological rigor in the field.  This article serves as an 
introduction to four separate reviews of the findings and methods used in cross-cultural studies 
of vasomotor, psychological, somatic, and sexual symptoms at midlife.   
Medline, PsycINFO, CINAHL and Google Scholar were searched for English-language 
articles published from 2005-2010 using the terms “cross cultural comparison” and 
“menopause.”  From the results of these searches, 8 studies fully met the following criteria:  they 
included more than one culture (country or ethnic) group and asked about actual symptom 
experience (not symptom expectation or symptoms attributed to menopause).  This review 
demonstrates considerable variation across studies in age ranges, symptom lists, reference period 
for symptom recall, variables included in multivariate analyses, and the measurement of factors 
(e.g., menopausal status and hormonal factors, demographic, anthropometric, mental/physical 
health, and lifestyle measures) that influence vasomotor, psychological, somatic and sexual 
symptoms.   
Our recommendations regarding age range, symptom lists, reference/recall periods, and 
measurement of menopausal status are given here.  Recommendations specific to the cross-
cultural study of vasomotor, psychological, somatic, and sexual symptoms are found in the four 
reviews that follow this introduction. 
 
Keywords:  
Menopause 
Cross cultural comparison 
Methodology 
Symptom reporting 
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1. Introduction 
 This is the introduction to a series of reviews, the purpose of which is to examine: (a) the 
methods used in cross-cultural comparisons of vasomotor [1], psychological [2], somatic [3], and 
sexual [4] symptoms at midlife; (b) the frequency of symptoms across culture/ethnic groups; and 
(c) the determinants of these symptoms and how they were measured. Finally we propose 
guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) Studies, a 
checklist of items that should be included in all reports of observational studies of menopause to 
enable cross-cultural and cross-population comparisons. Although several recent cross-cultural 
reviews of menopausal symptoms have been published [5, 6], conclusions and interpretations are 
constrained by methodological limitations that make rigorous comparisons across studies 
difficult. Symptom prevalence rates show considerable cross-cultural variation [5, 6], but it is 
unclear how such variation should be interpreted given methodological differences in variables 
such as recall period, population composition (age and menopausal status), and outcome 
measures (frequency, severity, and/or bothersomeness,). Until individual studies use consistent, 
comparable measures, cross-cultural comparisons across studies will be severely limited.  
 If our aim is cross-cultural comparisons of menopausal symptoms, how do we measure 
culture?  Are variables such as country of residence [7], or ethnicity [8, 9] good proxy measures 
for culture?  Do these differences disappear if relevant aspects of culture such as 
sociodemographics, health, lifestyle, and social circumstances [10], or education, language and 
acculturation [8] are controlled for?  The Study of Women Across the Nation (SWAN) has 
identified significant cultural/ethnic differences in rates of smoking, exposure to passive smoke, 
alcohol intake, phytoestrogen consumption, BMI and weight, physical activity, rates of 
hysterectomy, and age at menopause – which may partly explain the differences in symptom 
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reporting [8], and indeed most ethnic differences in health-related quality of life disappeared 
after controlling for confounders and covariates [10].  In contrast, in other studies such as 
DAMeS [11], country of residence appears to be a significant symptom determinant even after 
controlling for a number of potential confounders.  For the purpose of these reviews, we defined 
culture as either a country (in cross-country studies) or an ethnicity within a single nation. 
 A 2006 NIH-sponsored workshop on cross-cultural comparisons of menopause 
highlighted a number of issues, including whether menopause is a clearly-bounded entity and the 
role of culture in the perception and manifestations of menopause [12].  One key question is 
which symptoms, if any, constitute core menopausal symptoms, and should be included in all 
studies to enable cross-cultural comparisons.  In the 2005 NIH consensus statement on 
menopausal symptoms, only hot flushes, night sweats, vaginal dryness and perhaps trouble 
sleeping were found to be reliably related to the menopausal transition [13], yet other research 
has found additional symptoms that peaked around menopause [14].  Another key question is 
concerned with which factors (eg, menopausal status and hormones, demographic, 
anthropometric, health, and lifestyle) influence the experience and reporting of those symptoms. 
Our goal in this paper is to review the methodologies currently used in the field of menopausal 
symptom research and to make recommendations for study design, symptom measurement and 
assessment, and reporting of results in order to facilitate rigorous cross-cultural comparisons 
across studies in the future. 
Standardization of studies as outlined in our STROMA guidelines is necessary to 
facilitate cross-cultural comparisons, although attention to local variation in symptomatology is 
also required for a complete understanding of the variation in menopausal experience. 
Identifying the symptoms that are most bothersome to women during the menopausal transition 
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and distinguishing between those that are due to hormonal changes and those having aging- or 
socially-related etiology, is crucial for research, clinical care and public health policy. 
 
2. Methods 
 In this overview we describe sample characteristics, age ranges, reference periods for 
symptom report, and definitions of menopause (Table 1), and make general recommendations to 
facilitate future cross-cultural research. In the subsequent symptom-specific reviews, methods of 
assessment, terminology for naming symptoms, symptom frequencies, and symptom 
determinants are compared to the extent possible for vasomotor, psychological, somatic and 
sexual symptoms.   
[Table 1 goes about here] 
 
We made a priori groupings of symptoms into vasomotor, psychological, somatic and 
sexual symptom categories despite overlaps.  For example, palpitations, shortness of breath, 
fatigue, and dizziness are included in both psychological and somatic reviews (Table 2).  These 
somatic symptoms may be due to physiological causation or disease.  On the other hand, they 
may represent somatization of negative emotions or idioms of distress associated with anxiety or 
depression [15-17].  Sleep difficulties can overlap with several symptom groups, as they can 
result from psychological issues, sleep apnea or night sweats. Factor analyses suggest that 
fatigue, chest pain, dizziness, gastro-intestinal complaints, headaches, palpitations, numbness, 
and body aches at times cluster with psychological symptoms in some of the studies reviewed 
here [18-21].  The definitions and overlap of symptom groups are an important research area, 
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and existing research using factor analyses suggests that symptoms will not group in the same 
ways across cultures [21].  
[Table 2 goes about here.] 
 
To identify a new generation of cross-cultural studies, published since a previous review [6], 
PubMed, PsycINFO, CINAHL and Google Scholar were searched for English-language articles 
published from 2004-2010 using the terms “cross cultural comparison” and “menopause.”  
Additionally, PubMed was searched for references related to specific symptom groups, 
methodologies, and associated factors.  References of retrieved articles and reviews were hand-
searched.  Furthermore, studies and references that came to our attention at the Boston workshop 
[12] were also reviewed.  Most studies are described in multiple publications.  Criteria for the 
studies were an explicit cross-cultural or multi-ethnic design using similar methodologies across 
all sites/groups within each study, and explicit query and report of symptom experience in 
general, not clinical, populations.  Across all sources, we identified 11 studies relevant to our 
aims: 8 are included in all four of the reviews that make up this series; 1 study is included in just 
two reviews; and 2 studies were excluded. Kowalcek et al. [22] conducted a cross-cultural study 
of pre- and postmenopausal women in Germany and Papua New Guinea, and queried expected, 
not experienced, menopausal problems among pre-menopausal women.  Only post-menopausal 
women answered questions about their experience of menopausal problems (n=81).  Krajewska-
Ferishah et al. [23] conducted a cross-cultural study of QOL among women in Poland, Greece, 
Belarus and Belgium using the MRS scale, but only reported combined scores not individual 
symptoms. The Mid-Age Health in Women from the Indian Subcontinent (MAHWIS) study 
asked women in Birmingham, UK (n=103) and Delhi, India (n=50) to complete the Women’s 
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Health Questionnaire (WHQ) [24]. Some (i.e., hot flushes, night sweats, vaginal dryness, and 
sexual satisfaction), but not all (i.e., psychological and somatic), symptom frequencies are 
published in text, not table, form [25].  Symptom frequencies from the MAHWIS study are 
included in only the vasomotor {Melby, in press #22896}. and sexual {Anderson, in press 
#22894} symptom review papers. The 8 studies included in all reviews are described below/or in 
Table 1. 
 
2.1. Australian/ Japanese Midlife Women’s Health Study (AJMWHS) 
 The aim of the AJMWHS was to explore the midlife experience of women living in 
Australia and Japan.  Women were randomly selected by postal code from electoral rolls in 
Queensland and Nagano prefecture.  The Greene Climacteric Scale [26] was used to measure the 
extent to which a woman is currently bothered by 21 symptoms on a scale of “not at all”, “a 
little”, “quite a bit”, and “extremely”.  Analyses were performed to assess the influence of 
country of residence and menopausal status [7].    
 
2.2. Decisions At Menopause Study (DAMeS) 
 The DAMeS was carried out to compare systematically the symptomatology of 
menopause across four countries that differ in terms of health services, construction of gender, 
and cultural notions of aging and health [11].  Sample recruitment was based on the: (a) 
sampling frame of the Population Laboratory of the American University of Beirut (Beirut, 
Lebanon); (b) sampling frame of the national Pan Arab Child Health Survey (Rabat, Morocco); 
(c) membership records of the Fallon Community Health Plan (FCHP), a mixed-model health 
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maintenance organization (Masschusetts, USA); and (d) random sample of women drawn from 
census lists in 20 districts (Madrid, Spain) 
 The Everyday Complaint Listt [27, 28], which embeds ‘typical’ menopause symptoms 
within a larger list of general health symptoms in order to reduce the likelihood that responses 
conform to prevalent stereotypes, was used as the base for the 25-item symptom list [11, 21], and 
translated and piloted in all countries.  Women were asked:  “During the past month, have you 
experienced any of the following?” In the U.S. and Spain, each symptom was recorded as yes/no.  
In Morocco and Lebanon, each symptom was recorded as never, regular or occasionally [29, 30].  
   
2.3.  Four Major Ethnic Groups (FMEG) 
 The purpose of the FMEG study was to examine ethnic differences in symptom 
experience during the menopausal transition among 512 women aged 40-60 across 
geographically dispersed areas.  Internet communities formed by middle-aged women and 
internet groups for ethnic minorities formed by churches, organizations, health care centers, and 
professional groups were contacted and asked to announce the study.  Self-reported ethnicity 
included Hispanic, non-Hispanic white, non-Hispanic African American, and non-Hispanic 
Asian [31].  The Midlife Women’s Symptom Index [32] was used to query the presence and 
severity of 73 vasomotor, physical, psychological, and psychosomatic symptoms during the past 
6 months.   Stepwise regression analyses were carried out to assess the determinants of the total 
number of menopausal symptoms [31]. 
 
2.4. Hilo Women’s Health Survey (HWHS) 
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 This cross-sectional study surveyed women’s health in the multi-ethnic city of Hilo, 
Hawaii.  A random sample of households was selected using the County Map of Hawaii website 
to access tax map keys in the district of Hilo [33].  Household return rate was 28.5%; 1824 
women aged 16-100 returned the survey.  Ethnic groups included women of European, Japanese, 
Chinese, Filipino, and mixed Hawaiian descent.  Among women aged 40-60, European-
American (n=203) and Japanese-American (n=249) women represent the largest ethnic 
subgroups [33]. 
 The Everyday Complaint List (described above in 2.2) was modified for use in the 
HWHS following the piloting of the survey to women of European, Japanese, Chinese, and 
mixed ancestry[33]. Women were asked: “Thinking back over the past 2 weeks, have you ever 
been bothered by any of the following?” Participants were then presented with a list of 30 
symptoms.  Each symptom was recorded as yes/no.  
 
2.5. Mid-Aged Health in Women from the Indian Subcontinent (MAHWIS)  
 MAHWIS was a cross-sectional, quantitative and qualitative interview study that 
compared Indian and white women living in Birmingham, UK, and Asian women living in 
Delhi, India.  Women were recruited from the patient records of five general practitioners in 
Birmingham and by face-to-face recruitment and snowball techniques in Delhi.  The Women’s 
Health Questionnaire (WHQ) was used to measure 9 areas of symptom experience during the 
past 2 weeks [24, 25, 34].  In addition to vasomotor symptom frequencies, mean subscale scores 
are reported for depressed mood, somatic symptoms, vasomotor symptoms, anxiety/fears, sexual 
behavior, sleep problems, menstrual symptoms, memory/concentration, and attractiveness [25].  
As discussed above, MAHWIS is included in only the vasomotor and sexual reviews. 
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2.6. Penn Ovarian Aging Study  (POAS) 
 The POAS was a 10-year longitudinal population-based cohort study of European- and 
African-American women drawn from Philadelphia County, PA.  Women were identified by 
random-digit dialing to 1,420 households.  Of these, 218 African Americans and 218 European 
Americans enrolled [35]. Data were obtained in individual in-person interviews at participants’ 
homes.  The study offered a prospective examination of symptoms early in the transition to 
menopause [36].  
 The Kupperman Menopausal Index [37] was used to develop the Menopause Symptom 
List (MSL) used in the POAS [19].  Participants were asked which of 12 symptoms occurred in 
the past month, the frequency of each symptom, and severity from 0 (none) to 3 (severe).  
Additional instruments were also used and are described in the relevant reviews that follow.  
  
2.7. Study of Women's Health Across the Nation (SWAN) 
 The goal of the SWAN was to describe the chronology of the biological and psychosocial 
characteristics of the menopausal transition and its effect on health and risk factors for age-
related chronic diseases.  Community-based samples of women were drawn from seven U.S. 
cities.  Women self-identified as Caucasian (all sites), African-American (four sites), Chinese 
(one site), Hispanic (one site), and Japanese (one site) [18].  Twelve symptoms were selected 
from the Everyday Complaint Checklist and symptom presence during the past 2 weeks was 
queried [9, 18, 38-40] 
 
2.8.  Women’s Health in Midlife National Study (WHiMNS)  
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 The aim of this study was to examine differences in symptom reports and symptom 
clusters among women from different cultural origins living in Israel [20].  Women aged 45-64 
were drawn from three groups: long term Jewish residents who arrived before 1989, Jewish 
immigrants who arrived from the former Soviet Union after 1989, and Arab Israelis.   
Participants were selected randomly from the National Population Registry, stratified by age and 
population group.  A list of 16 symptoms experienced over the past 6 months was developed 
from three instruments [41-43].  Each positive response was followed by a question about how 
bothersome the symptom was on a 4 point Likert scale.  Results are presented as the frequency of 
symptoms reported as bothersome.  Factor analyses were used to create two scales for 
multivariate analyses:  a mental symptom scale and a general somatic symptoms scale. 
 
2.9. Women’s International Study of Health and Sexuality (WISHeS) 
 The objectives of WISHeS were to depict patterns of symptoms across age and 
reproductive stages and to examine factors affecting symptom prevalence including country of 
origin.  Women were recruited in France, Germany, the U.S. and U.K. through market research 
panels [14].  In Italy, recruitment was random, through door to door visits.  Women with a 
history of hysterectomy, with and without bilateral oophorectomy, were purposefully recruited 
along with pre-, peri-, and naturally postmenopausal women.  Symptom experience over the past 
month was queried for 29 symptoms derived from MENQOL [42] plus 7 additional symptoms. 
Bothersomeness was rated on a 7 point Likert scale, and symptoms were distinguished for 
analyses as clinically significant (≥3 on the scale of bothersomeness) or not (<3). A linear 
regression model for estimated prevalence at age 50 was constructed. 
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3. Results 
 The “Sample characteristics” column of Table 1 shows differences in age range across 
studies, from a narrow age range of 45-55 years [11] to a broad range of 20-70 [14].  Since age is 
associated with symptom experience, these age ranges most likely influence the symptom 
frequencies reported in the reviews that follow.  There is more uniformity in methods of 
recruitment.  All studies used general population (not clinical) samples, although records of 
general practitioners were used to identify women in the UK (MAHWIS) and HMO records were 
used to recruit women in the US (DAMeS).  These women were not, however, seeking assistance 
for concerns related to menopause.  Most of the studies recruited samples through some type of 
randomized list, with the exception of snowball sampling among Hispanic and Japanese 
participants in the US (SWAN), Indian participants in Delhi (MAHWIS), and targeted internet 
sites (FMEG).  Data collection ranged from face-to-face interviews to postal, telephone, and 
internet surveys.  Six different symptom lists were employed, and the reference period for 
symptom recall ranged from current symptoms (AJMWHS) to the past two weeks (HWHS, 
MAHWIS, SWAN), four weeks (DAMeS, POAS, WISHeS) and six months (FMEG, WHiMNS).  
Some questionnaires only asked about the presence/absence of symptoms (HWHS, MAHWIS, 
SWAN), while others included scales of severity (AJMWHS, FMEG), and/or a question specific 
to the bothersomeness of symptoms (DAMeS, HWHS, WISHeS).  Factors included in 
multivariate analyses, and the measurement of those factors, were similarly variable across 
studies (Table 3). 
 
[Table 3 goes about here.] 
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 Table 3 lists the factors examined in relation to symptom frequencies in each study.  Not 
all symptoms were examined in multivariate models.  For example, in the HWHS only the 
presence/absence of hot flushes and night sweats were the outcomes of multivariate models.  In 
the POAS, severity of hot flushes, aches/joint pain/stiffness, depressed mood, poor sleep, 
decreased libido, and vaginal dryness were examined in linear regression models.  How these 
factors were assessed varies across studies, as illustrated with the example of menopausal status 
(Table 4).   
[Table 4 goes about here.] 
 
4. Discussion and recommendations 
4.1 Age range 
A broad age range facilitates the testing of hypotheses about aging vs. menopause 
(WISHeS).  For longitudinal studies, it makes sense to start with a relatively young age range in 
order to follow women through the menopausal transition (SWAN, POAS).  It is more difficult 
to recommend a firm age range for cross-sectional studies.  Since median ages at menopause 
tend to be younger in developing countries [44], cross-sectional studies that involve developing 
countries should include women younger than 45 to capture the perimenopausal experience.  
However, in western, post-industrial countries, the median ages at menopause hover between 50 
and 52, suggesting that studies of the menopausal transition should begin around 45.  For cross-
cultural work, we recommend the age range of 45 to 55, but encourage culture-specific flexibility 
to sample women aged 40-60 to better embrace variability in reproductive aging where relevant. 
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4.2 Menopausal status 
There is variation in the definition of menopause (Table 4) and in inclusion/exclusion of 
women across studies.  We advocate for staging the menopausal transition based on the 
consensus statement from the Stages of Reproductive Aging Workshop (STRAW) [45].  This 
involves asking women about more than their last menstrual period and history of hysterectomy.  
For example in the POAS, menopausal stage was assessed using menstrual dates, daily symptom 
diaries, number of menstrual periods between assessments, cycle length, and number of bleeding 
days.  Follicle stimulating hormone (FSH), Anti-Mullerian Hormone (AMH), and inhibin-B 
levels can be combined with menstrual history to place women into stages; however, hormonal 
fluctuations during the peri-menopause limit the utility of one-time hormone measurements for 
identifying menopausal status. 
 
4.3 Reference period 
Most studies use either 2 week or 1 month recall. Asking women about symptom 
experience during the past 2 weeks does not necessarily capture the experience of peri-
menopausal women who may have frequent hot flushes one month, but no hot flushes the next as 
hormone levels fluctuate from pre- to post-menopausal levels.  A 4-week reference period is 
more likely to capture the erratic nature of hot flushes and give a more accurate sense of who is 
symptomatic.    Ideally, someone should do a study with both, since we do not have good data on 
how these relate, e.g., are 1 month recall symptom frequencies similar to, or double, 2 week 
recall symptom frequencies?  Asking about symptom experience during the past 6 months makes 
it difficult to match symptom experience with stress, diet, or activity patterns at the time of 
interview.  Long (>1 month) or ambiguous recall periods should not be used. 
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4.4 Symptom assessment 
Six different symptom lists were used in the studies reviewed here, highlighting the 
difficulty encountered when trying to draw comparisons across studies.  Instruments should refer 
to a core group of symptoms experienced everywhere (Table 5), but the exact formulation of the 
questions about symptoms may be adjusted to the nuances with which they are perceived and 
expressed across cultures.  One of the primary methodological challenges with conducting cross-
cultural studies of menopausal symptoms is ensuring measurement equivalence (measuring the 
same construct with similar precision across different populations), which involves translation of 
questions and response categories to ensure similar interpretations  [8].  In addition to core 
symptoms, there is also a need to add local- or population-specific symptoms [46].  The study 
should be framed and presented to participants as general research about women’s health to 
avoid the reporting bias that can occur if women are asked only about menopausal symptoms, or 
if they know or believe the study to be primarily about menopause.  An overall measure of 
symptom burden and reporting can help determine whether systematic over- or under-reporting 
at some sites or in some subgroups exists, e.g., among the Japanese-Americans in Hilo (Brown et 
al. 2009). Embedding menopausal symptoms in an everyday complaint list also permits 
assessment of overall symptom reporting. Asking about general health assessment might also be 
useful to compare morbidity in populations. 
 
[Table 5 goes about here.] 
 
4.5 Symptom bothersomeness 
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We also recommend that in addition to symptom presence (yes/no) or frequency, 
researchers investigate bothersomeness for a measure of how symptom experience affects quality 
of life.  Questions about bothersomeness or interference with daily life would have to be 
measured in a way that is adapted to cultural context [8].   
 
4.6 Subjective/objective measures 
Where possible, objective measures avoid the problem of cultural reporting bias [47, 48] 
and provide an alternative source of information about symptom experience.  For example, 
objective hot flush measurement using sternal skin conductance provides a measure of sweating 
that indicates a physiological hot flush, whether a woman experiences the hot flush or not [49, 
50].  These objective measures have shown differences in hot flush frequencies related to 
religious practices [51] that a study of subjective report would have missed.  Measures of 
flexibility, muscle strength, and balance [52, 53] can be used to supplement subjective somatic 
symptom reports.  
 
4.7 Reporting of data 
Reporting of datais almost as important as symptom assessment for cross-study 
comparisons.  We recommend that symptom groupings within frequency tables be based on 
culture-specific evidence, e.g., from factor analyses.  We recommend that frequencies be given 
for all symptoms queried.  When studies do not report individual symptoms, but rather groupings 
and scales, then symptom frequencies cannot be compared.  The constituent symptoms of the 
subscales and symptom groups vary considerably between studies and instruments used, making 
comparisons between studies almost impossible.  Researchers carry out multi-part studies that 
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lend themselves to a number of publications with different foci.  One result of this strategy can 
be the lack of a simple symptom frequency overview.  Also, as shown in Table 3, not all 
symptoms are examined using multivariate analyses.  The studies reviewed here are recent, and 
not all of their results have been published.  We advocate for a symptom frequency list that 
makes cross-study comparisons possible. We also recommend that symptom frequencies be 
reported by menopausal status subgroups, in addition to total symptom frequencies.   
 
4.8 Analysis and modeling of data 
The use of different methodology, instruments and checklists increases the difficulty of 
making comparisons, but comparisons are also made difficult by variation in analyses.  It is 
encouraging to see researchers move beyond simple bivariate associations to investigate more 
complex relationships.  More sophisticated models allow for the assessment of symptom change 
across longitudinal studies (POAS), or permit the separation of menopause and aging effects 
using not just linear but non-linear relationships (eg, quadratic relationships with age), especially 
for symptoms that are expected to peak at menopause (WISHeS).  In WISHeS, analyses 
distinguished between symptoms influenced by natural aging (predicted to show a linear 
relationship with age) versus those influenced by hormonal changes of menopause (predicted to 
show an inverted U-shaped curve; using age2 in models) [14].  Presentation of the results was 
done in the form of a table of coefficients for relevant variables (such as age, age2, mental and 
physical morbidity, early surgery, BMI), allowing others to estimate symptom prevalence for 
populations with particular characteristics (such as surgical menopause or low vs. high co-
morbidities). [14], 
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Ideally we would have liked to have been able to provide cross-cultural estimates for the 
contributions of various demographic, socioeconomic and anthropometric factors to the 
variability of symptom prevalence and severity.  However, the factors included in multivariate 
models varied widely among studies.  Also, in some populations, inadequate variation in factors 
may prevent the observation of relationships among them. For example, in a population with a 
high mean BMI, the BMI range may be narrow, thus preventing the observation of relationships 
between body fat and symptoms.  Data that should be systematically included in multivariate 
models include : menopausal status (based on STRAW) and hormonal measures (mean values 
and variance); demographic data (age, country/ethnicity); anthropometric data (BMI, waist 
circumference);  mental and physical health morbidity details (self-assessment of general, 
physical/mental health (particularly depression, anxiety, and perceived stress); lifestyle-related 
behaviors (smoking, alcohol consumption, diet, exercise/activity level), as well as cultural 
factors (religion, acculturation, medicalization and attitudes toward menstruation, menopause, 
and aging).  Ideally, BMI and waist circumference (a measure of fat patterning) would be 
measured by the researcher rather than self-reported.  These measurements are inexpensive, 
quick, and noninvasive.  Specifics of diet, e.g. food rich in phytoestrogens, amounts of fruit and 
vegetables eaten per day, meat, daily calcium, and caffeine intake, would facilitate comparison 
of studies. 
 Few studies conform to the guidelines outlined in STROBE (STrengthening the 
Reporting of OBservational studies in Epidemiology) [54] – and we would like to recommend 
that future population studies of menopausal symptoms follow their checklist (available free 
from www.strobe-statement.org) to enable study comparisons.  In addition to the STROBE 
guidelines, we propose guidelines for Strengthening The Reporting Of Menopause & Aging 
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(STROMA) studies (Table 6), where we list study design, analysis and reporting requirements 
and recommendations for future cross-cultural comparisons of menopause. 
 
5. Conclusions 
 In our review of the cross-cultural studies described above, we noted a serious bias 
toward a focus on vasomotor symptoms.  We have tried to balance that bias by reviewing 
psychological, somatic and sexual symptoms as well.  While many non-vasomotor symptoms 
may not have their origin in the hormonal changes of the perimenopause, they may be 
exacerbated by such changes.  In some of the studies reviewed here, somatic symptoms were 
reported more frequently than vasomotor symptoms.  We have also tried to highlight the 
interconnectedness and multi-directional influences of symptoms on each other: (a) anxiety and 
depression may influence vasomotor and sexual symptoms; (b) vasomotor symptoms may affect 
sleep; (c) somatic and sexual symptoms may cause depression; (d) psychological symptoms may 
be somaticized.     
Although some researchers may be primarily interested in vasomotor symptoms, we 
recommend that measures of mental and physical morbidity be included in any cross-cultural 
study of menopausal symptoms, as these often vary by ethnic/culture group and contribute 
significantly to prevalence rates (or bothersome rates).  In longitudinal studies, psychological 
symptoms such as anxiety and depression often precede, and appear to influence rates of, 
vasomotor symptoms [35, 55]. These results highlight the difficulty of separating symptoms into 
neat categories or domains, and argue for the collection of data on some symptoms in all 4 
domains in any study.  Guidelines for Strengthening The Reporting Of Menopause & Aging 
(STROMA) studies are provided in Table 6, and we hope that future researchers will endeavor 
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to collect and report these data, and that journals will publish all data necessary to facilitate 
rigorous cross-cultural comparisons. 
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